Health Tech Insights: 5 Startups Backed by VC Jon Medved That Could Transform Care

In October, Israel lost a public champion when renowned venture capitalist Jon Medved retired following his diagnosis with Amyotrophic Lateral Sclerosis (ALS). His unique perspective as both investor and patient offers rare insight into health tech's transformative power.

• OurCrowd leads with 500 portfolio companies and 74 notable exits.
• Recent $525 million exit highlights the ecosystem's vitality.

Will you consider health tech startups in your portfolio after this story?

ALS progressively impairs muscle control, impacting speech, movement, and breathing. Medved's case is unique; his voice was affected first, a factor that informed how he uses tech innovation to maintain communication.

Key tech assisting ALS patients includes:

1. AI-generated avatars for communication.
2. Voice synthesis technologies.
3. Genome sequencing for personalized therapy.

What health tech solutions do you believe hold the most promise for chronic diseases?

Medved's firm, OurCrowd, has invested heavily in companies leveraging AI and advanced technologies to improve patient outcomes.

Key investments include:

• OncoHost: AI for cancer immunotherapy prediction.
• D-ID: creators of photorealistic avatars.
• ElevenLabs: pioneers in voice AI technology.

Could AI-driven personalized medicine be the future healthcare frontier?

Despite geopolitical challenges, Israel's "Startup Nation" continues to thrive, particularly in health tech.

Other metrics:

• Nearly 100 unicorns in Israel.
• $15-$16 billion invested in venture deals annually.

Are you monitoring emerging markets like Israel for tech innovation opportunities?

Medved’s dual role as VC and patient spotlights the importance of investing in meaningful technologies that improve quality of life.

Investor action steps:

1. Explore health tech startups with patient-centric solutions.
2. Evaluate AI applications in chronic disease management.
3. Monitor Israeli VC market trends for growth prospects.

Would you support ventures led by founders personally impacted by the medical challenges their tech addresses?

• OncoHost: AI immunotherapy prediction.
• D-ID: Digital avatars for communication.
• ElevenLabs: Advanced voice AI.
• Genome sequencing startups.
• Chronic condition management platforms.

These companies illustrate health tech’s potential to revolutionize care.

Consider which innovations align with your investment strategy.

How confident are you in investing in health tech startups addressing chronic illnesses like ALS?

— Options: Very Confident, Somewhat Confident, Neutral, Unsure, Not Interested

• Jon Medved, Israeli VC, leverages health tech personally amid ALS diagnosis.
• OurCrowd powers innovative startups in AI, avatars, genome sequencing.
• Israel maintains robust venture capital investments despite geopolitical risks.
• Investors should consider patient-driven health tech innovation opportunities.
• Tracking Israeli startups offers a pathway to impactful, tech-enabled care.

Disclaimer: This article is for informational purposes only and not investment advice. Consult financial advisors before making investment decisions.